<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03228602</url>
  </required_header>
  <id_info>
    <org_study_id>JACQUIN PEGASE 2016</org_study_id>
    <nct_id>NCT03228602</nct_id>
  </id_info>
  <brief_title>Impaired Gustatory Sensory Perception in Obese and Obese Diabetic Persons</brief_title>
  <acronym>PEGASE</acronym>
  <official_title>Gustatory Evoked Potentials and Cerebral Control of Food Intake in Obese Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Dijon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire Dijon</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to compare several parameters in three distinct groups of subjects:
      persons with obesity, persons with obesity and diabetes and persons with neither obesity nor
      diabetes:

        -  the electrical activity in response to a sweet solution, measured before and after a
           standard meal, using gustatory evoked potentials (recording explained below)

        -  blood hormone levels related to weight gain (insulin, dopamine, ghrelin, leptin:
           measured in blood samples)

        -  levels of activity and quantity of an enzyme present in the saliva, amylase, which is
           able to break down ingested starch into several molecules of glucose.

      All of these parameters will be correlated to determine whether the results are different in
      the 3 groups of subjects in the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 11, 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amplitude of the gustatory evoked potential</measure>
    <time_frame>Up to 10 days</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Latency of the gustatory evoked potential</measure>
    <time_frame>Up to 10 days</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>healthy subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>obese</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>obese diabetic</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Recording of GEP (Gustatory Evoked Potentials)</intervention_name>
    <description>record cerebral activity thanks to electrodes placed on the head and fixed with a painless, harmless adhesive paste and linked to a computer equipped with specific software to interpret the signals obtained. The collection of data for the electric signal takes 20 minutes.</description>
    <arm_group_label>healthy subjects</arm_group_label>
    <arm_group_label>obese</arm_group_label>
    <arm_group_label>obese diabetic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have provided written consent

          -  Patients over 18 years old

          -  Body Mass Index (BMI) &lt;25 kg/m² for healthy volunteers and BMI≥30 kg/m² for obese
             subjects

          -  Patients with type 2 diabetes for the group &quot;obese diabetic subjects&quot;

        Exclusion Criteria:

          -  Patients under guardianship

          -  Patients without health insurance cover

          -  Pregnant or breast-feeding women

          -  Active smokers

          -  Subjects with type 2 diabetes for the &quot; healthy subjects &quot; and &quot; obese subjects &quot;,
             subjects with type 1 diabetes for all groups

          -  Subjects who do not speak French

          -  Treatment that interferes with taste or acts on the central nervous system

          -  Anti-diabetic treatment with GLP-1 analogues (Glucagon-like peptide 1) or SGLT2
             (sodium-glucose cotransporter type 2)

          -  Known hypersensitivity to the foods proposed in the study, or the paste used to fix
             the electrodes, or to paraffin wax or to the products tested (sucrose, glucose or
             starch for the gustatory evoked potentials and triangular tests)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Agnès JACQUIN-PIQUES</last_name>
    <phone>3 80 29 37 54</phone>
    <phone_ext>+33</phone_ext>
    <email>agnes.jacquin-piques@chu-dijon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Dijon Bourgogne</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Agnès JACQUIN-PIQUES</last_name>
      <phone>3 80 29 37 54</phone>
      <phone_ext>+33</phone_ext>
      <email>agnes.jacquin-piques@chu-dijon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 25, 2017</study_first_posted>
  <last_update_submitted>July 21, 2017</last_update_submitted>
  <last_update_submitted_qc>July 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

